Results from ENESTgoal: A phase 2 study of treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) who switched from imatinib to nilotinib Meeting Abstract
| Authors: | Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Pinilla-Ibarz, J.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Dautaj, I.; Purkayastha, D.; Habucky, K.; Mauro, M. J. |
| Abstract Title: | Results from ENESTgoal: A phase 2 study of treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) who switched from imatinib to nilotinib |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419700075 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.2875.2875 |
| Notes: | Meeting Abstract: 2875 -- Source: Wos |
